Processa pharmaceuticals to present at the h.c. wainwright 25th annual global investment conference

Hanover, md, sept. 06, 2023 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (“processa” or the “company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that chief executive officer george ng will present a corporate overview at the at the h.c. wainwright 25th annual global investment conference. the conference is being held on september 11 – 13, 2023 at the lotte new york palace hotel.
PCSA Ratings Summary
PCSA Quant Ranking